Literature DB >> 2979223

Gastrointestinal transit of an enteric-coated delayed-release 5-aminosalicylic acid tablet.

J G Hardy1, J N Healey, S W Lee, J R Reynolds.   

Abstract

Gastrointestinal transit of an enteric-coated, delayed-release 5-aminosalicylic acid tablet radiolabelled with indium-111 has been monitored in a preliminary study with eight healthy subjects using gamma scintigraphy. Gastric emptying of the tablet was delayed by the presence of food in the stomach. Disintegration occurred about 5 hours after the tablet left the stomach. There was close agreement between the tablet disintegration times and the initial detection of drug in the blood. The site of disintegration could be established in most instances; approximately 80% of the doses resulted in drug dispersion within the ascending colon. The coated tablets provide an effective means of drug delivery to the proximal colon.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2979223     DOI: 10.1111/j.1365-2036.1987.tb00620.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  10 in total

Review 1.  Gamma scintigraphy in the evaluation of pharmaceutical dosage forms.

Authors:  S S Davis; J G Hardy; S P Newman; I R Wilding
Journal:  Eur J Nucl Med       Date:  1992

2.  Gastric emptying of indigestible tablets in relation to composition and time of ingestion of meals studied by metal detector.

Authors:  K Ewe; A G Press; S Bollen; I Schuhn
Journal:  Dig Dis Sci       Date:  1991-02       Impact factor: 3.199

Review 3.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

4.  Prandial and diurnal effects on the absorption of orally administered enteric coated 5-aminosalicylic acid (5-ASA).

Authors:  C De Mey; I Meineke
Journal:  Br J Clin Pharmacol       Date:  1992-02       Impact factor: 4.335

Review 5.  [Pharmacokinetic data for different 5-aminosalicylic acid and budesonide preparations].

Authors:  U Klotz
Journal:  Med Klin (Munich)       Date:  1999-02-15

6.  Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion.

Authors:  L Staerk Laursen; M Stokholm; K Bukhave; J Rask-Madsen; K Lauritsen
Journal:  Gut       Date:  1990-11       Impact factor: 23.059

Review 7.  Budding Multi-matrix Technology-a Retrospective Approach, Deep Insights, and Future Perspectives.

Authors:  Anitha Sriram; Suma Tangirala; Srividya Atmakuri; Sajid Hoque; Sheela Modani; Saurabh Srivastava; Srushti Mahajan; Indrani Maji; Rahul Kumar; Dharmendra Khatri; Jitender Madan; Pankaj Kumar Singh
Journal:  AAPS PharmSciTech       Date:  2021-11-03       Impact factor: 3.246

8.  In vivo evaluation of enteric-coated naproxen tablets using gamma scintigraphy.

Authors:  I R Wilding; J G Hardy; R A Sparrow; S S Davis; P B Daly; J R English
Journal:  Pharm Res       Date:  1992-11       Impact factor: 4.200

9.  Oroileal transit of slow release 5-aminosalicylic acid.

Authors:  H Goebell; U Klotz; B Nehlsen; P Layer
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

10.  Absolute bioavailability and regional absorption of ticagrelor in healthy volunteers.

Authors:  Renli Teng; Juan Maya
Journal:  J Drug Assess       Date:  2014-08-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.